- Home
- BOKF vs AXSM Comparison
BOKF vs AXSM Comparison
Compare BOKF & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOKF | AXSM |
|---|---|---|
| Founded | 1910 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 9.0B |
| IPO Year | 2007 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BOKF | AXSM |
|---|---|---|
| Price | $127.55 | $157.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $127.10 | ★ $209.18 |
| AVG Volume (30 Days) | 295.9K | ★ 514.2K |
| Earning Date | 04-20-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | 12.65 | ★ 38.56 |
| EPS | ★ 9.17 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.56 | $58.18 |
| Revenue Next Year | $5.35 | $55.45 |
| P/E Ratio | $13.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $85.08 | $86.99 |
| 52 Week High | $138.42 | $191.50 |
Technical Indicators
Market Signals| Indicator | BOKF | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.00 | 38.64 |
| Support Level | $121.15 | $153.37 |
| Resistance Level | $138.25 | $169.11 |
| Average True Range (ATR) | 2.90 | 3.91 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 62.91 | 25.61 |
Price Performance
Historical ComparisonAbout BOKF BOK Financial Corporation
BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.